Gadobutrol
- TRADE NAME: Gadovist (Bayer)
- INDICATIONS: Magnetic resonance imaging
- CLASS: Gadolinium-based contrast agent (GBCA)
- HALF-LIFE: 90 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amitriptyline, Arsenic, Citalopram, Dasatinib, Degarelix, Dolasetron, Lapatinib, Levofloxacin, Moxifloxacin, Pazopanib, Telavancin, Telithromycin, Voriconazole, Vorinostat, Ziprasidone
PREGNANCY CATEGORY: C
NEPHROGENIC SYSTEMIC FIBROSIS (NSF)
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 03/02/2024
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric